Rallybio 新闻与活动

Rallybio 是一家在股票代码 RLYB (US) 下上市的公司。

查看带有其 30 名主要高管的组织结构图

Rallybio 搜索最多的简介

• Stephen Uden, President, Chief Executive Officer and Director
• Martin Mackay, Executive Chairman of the Board
• Lucian Iancovici, Director

创建提醒
跟踪 Rallybio 的高管变动

Rallybio 拥有 2,347 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Genus (联合王国)。

Popular M&A news in 生物技术

•  (公布2025三月28号).
• Epic-Bio 刚刚宣布为 68 筹款数百万美元。 (公布2025三月28号).
• Ernexa Therapeutics的新名称是Ernexa Therapeutics。 (公布2025三月26号).

生物技术 行业的其他推荐联系人

• Scholar Rock 企业 Kristina Burow - Director
• VBI Vaccines 企业 Steven Gillis - Chairman of the Board
• Adaptimmune Therapeutics 企业 Ali Behbahani - Non-Executive Director

了解更多有关生物技术行业的信息 >

Rallybio 的最新新闻稿

• Newsroom | Page 2 | Rallybio
• Newsroom | Page 3 | Rallybio
• Rallybio Announces Clinical Proof of Concept for RLYB211, an Anti-HPA-1a Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) | Rallybio
• Rallybio Reveals Details of Two Pipeline Programs with the Potential to Transform the Lives of Patients with Rare Diseases | Rallybio
• Steven Tuch Joins Rallybio to Lead Corporate Development | Rallybio
• Rallybio to Present at the 3rd Annual Evercore ISI HealthCONx Conference | Rallybio
• Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study | Rallybio
• Rallybio to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference | Rallybio
• View more press releases Close

关于 Rallybio 的社交媒体

• Rallybio 在 维基百科、谷歌新闻 和 雅虎财经
• Rallybio 在 LinkedIn、叽叽喳喳 和 YouTube